These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23839180)

  • 1. Tolerability and irritation potential of four topical acne regimens in healthy subjects.
    Grove G; Zerweck C; Gwazdauskas J
    J Drugs Dermatol; 2013 Jun; 12(6):644-9. PubMed ID: 23839180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
    Ting W
    Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
    Goreshi R; Samrao A; Ehst BD
    J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
    Andres P; Pernin C; Poncet M
    Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
    Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB
    Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
    Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
    J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
    Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
    J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
    Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
    Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
    Kircik L; Green L; Thiboutot D; Tanghetti E; Wilson D; Dhawan S; Parr L
    J Drugs Dermatol; 2009 Sep; 8(9):812-8. PubMed ID: 19746673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
    Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S;
    J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How patients experience and manage dryness and irritation from acne treatment.
    Feldman SR; Chen DM
    J Drugs Dermatol; 2011 Jun; 10(6):605-8. PubMed ID: 21637901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.